Ole Isacson

Ole Isacson

McLean Hospital, Harvard Medical School

Affiliated withHarvard Medical School

Research Area

Biography

Ole Isacson has not added Biography.
If you are Ole Isacson and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2
Year
ES Cell-derived Neuroepithelial Cell Cultures
Publication title

Cited by 7

2006
2007

Other Publications

Article
Year
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 11782534

2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
Altered proteasomal function in sporadic Parkinson's disease.

Experimental neurology| PubMed ID: 12504866

2003
2003
2003
2003
2003
2003
2003
2004
2004
2004
2004
2004
2004
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 15509742

2004
2005
2005
2005
Stem cells may reshape the prospect of Parkinson's disease therapy.

Brain research. Molecular brain research| PubMed ID: 15790528

2005
2005
2005
2005
2005
2005
2006
Specific microRNAs modulate embryonic stem cell-derived neurogenesis.

Stem cells (Dayton, Ohio)| PubMed ID: 16357340

2006
2006
2006
2006
2006
2006
2007
2006
2007
2007
Inhibition of the dopamine D1 receptor signaling by PSD-95.

The Journal of biological chemistry| PubMed ID: 17369255

2007
2007
2007
2007
2007
An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 17670978

2007
2007
2007
Cell therapy and stem cells in animal models of motor neuron disorders.

The European journal of neuroscience| PubMed ID: 17897390

2007
2008
2008
Recent advances in cell-based therapy for Parkinson disease.

Neurosurgical focus| PubMed ID: 18341409

2008
2008
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 18391196

2008
2008
2008
2008
2008
2008
2008
Future of cell and gene therapies for Parkinson's disease.

Annals of neurology| PubMed ID: 19127583

2008
2009
PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 19261890

2009
2009
2009
2009
2009
2009
2009
No evidence for disease-like processes in fetal transplants.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 19805203

2009
2009
2009
Cell therapy ahead for Parkinson's disease.

Science (New York, N.Y.)| PubMed ID: 19965408

2009
Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 20007772

2009
High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 20181938

2010
2010
2010
2010
2010
Being too inclusive about synuclein inclusions.

Nature medicine| PubMed ID: 20823871

2010
2010
The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 21123556

2010
2011
2011
2011
Opportunities for neurorestorative therapies in PD using iPS and stem cells.

Rinshō shinkeigaku = Clinical neurology| PubMed ID: 21921494

2010
2012
2012
2012
Viral and inflammatory triggers of neurodegenerative diseases.

Science translational medicine| PubMed ID: 22344685

2012
2012
2012
2012
2012
Stem cells for Parkinson's disease: advancing science but protecting patients.

Movement disorders : official journal of the Movement Disorder Society| PubMed ID: 23032987

2012
2012
2013
2014
2014
Advances in stem-cell--generated transplantation therapy for Parkinson's disease.

Expert opinion on biological therapy| PubMed ID: 24437368

2014
2014
2014
2014
2014
2014
2015
2015
Sorting the wheat from the chaff in dopamine neuron-based cell therapies.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 25848026

2015